Gabelli Funds LLC Eli Lilly & CO Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gabelli Funds LLC holds 121,190 shares of LLY stock, worth $90.7 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

121,190

Previous 122,248 0.87%

Holding current value

$90.7 Million

Previous $111 Million 2.99%

% of portfolio

0.84%

Previous 0.9%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $816,924 - $1.02 Million	-1,058 Reduced 0.87%	121,190 $107 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $3.85 Million - $4.82 Million	-5,306 Reduced 4.16%	122,248 $111 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $413,355 - $553,011	698 Added 0.55%	127,554 $99.2 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $12.2 Million - $14.3 Million	23,135 Added 22.31%	126,856 $73.9 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $3.62 Million - $4.99 Million	-8,330 Reduced 7.43%	103,721 $55.7 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $7.24 Million - $9.68 Million	20,640 Added 22.58%	112,051 $52.5 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $22,365 - $26,267	72 Added 0.08%	91,411 $31.4 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $13.5 Million - $15.7 Million	41,939 Added 84.9%	91,339 $33.4 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $237,184 - $270,296	-800 Reduced 1.59%	49,400 $16 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $1.61 Million - $1.89 Million	-5,760 Reduced 10.29%	50,200 $16.3 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $443,200 - $545,420	-2,000 Reduced 3.45%	55,960 $12.9 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $361,100 - $467,080	-2,000 Reduced 3.34%	57,960 $13.3 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $1.75 Million - $2.03 Million	-12,000 Reduced 16.68%	59,960 $8.88 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $136,420 - $164,180	-1,000 Reduced 1.37%	71,960 $11.8 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $374,220 - $463,505	-3,500 Reduced 4.58%	72,960 $9.59 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $740,909 - $805,918	-6,938 Reduced 8.32%	76,460 $8.55 Million
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $7.09 Million - $8.35 Million	-63,702 Reduced 43.31%	83,398 $10.8 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $4.39 Million - $4.92 Million	-41,500 Reduced 22.0%	147,100 $17 Million
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $2.36 Million - $2.95 Million	-27,500 Reduced 12.73%	188,600 $20.2 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $1.28 Million - $1.47 Million	-16,900 Reduced 7.25%	216,100 $18.4 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $519,469 - $613,200	-7,000 Reduced 2.92%	233,000 $18 Million
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $6.06 Million - $6.5 Million	-74,000 Reduced 23.57%	240,000 $20.3 Million
Q3 2017 Nov 01, 2017	BUY	$77.07 - $85.54 $24.2 Million - $26.9 Million	314,000	314,000 $26.9 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Eli Lilly & CO Transaction History